NeuraSignal

📍 Los Angeles, United States👥 56 employees💰 Last funded Mar 2016
Medical Device🌐 neurasignal.com
Website LinkedIn
In 2023 NeuraSignal, Inc. acquired the business of NovaSignal, the original developer of NovaGuide. NeuraSignal is a medical technology company with a mission to save lives by unlocking the power of cerebral blood flow data. The company’s FDA-cleared NovaGuide Intelligent Ultrasound combines non-invasive ultrasound, robotics, and artificial intelligence to assess cerebral hemodynamics in real time. Using cloud computing and data analytics, NeuraSignal supports physicians in their clinical decision making in several neurological conditions including stroke, traumatic brain injury, and dementia. To learn more, visit www.NeuraSignal.com.
7
Total investors
5
Early stage
1
Mid stage
0
Late stage
—
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
6
Ukraine
1
Investor activity2014–2016 · investors recorded per year
2014620161
Recent (last 2y)Earlier
Frequently asked questions
Who invested in NeuraSignal?
NeuraSignal has 7 investors on record on gritt.io, including 5 early-stage backers, 1 mid-stage.
When did NeuraSignal last raise funding?
The most recent investment in NeuraSignal recorded on gritt.io was in March 2016.
What industry is NeuraSignal in?
NeuraSignal operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is NeuraSignal based?
NeuraSignal is headquartered in Los Angeles, United States.